FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

39168111000001100: Co-careldopa 12.5mg/50mg tablets (Medihealth (Northern) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 23-Dec 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1695851000001112 Co-careldopa 12.5mg/50mg tablets (Medihealth (Northern) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1695861000001110 Co-careldopa 12.5mg/50mg tablets (Medihealth (Northern) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-careldopa 12.5mg/50mg tablets (Medihealth (Northern) Ltd) Is a Co-careldopa 12.5mg/50mg tablets true Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Medihealth (Northern) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Medihealth (Northern) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Medihealth (Northern) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Medihealth (Northern) Ltd) Is a Co-careldopa 12.5mg/50mg tablets false Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Medihealth (Northern) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Medihealth (Northern) Ltd) Has specific active ingredient Levodopa true Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Medihealth (Northern) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Carbidopa true Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Medihealth (Northern) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Medihealth (Northern) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Medihealth (Northern) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Medihealth (Northern) Ltd) Has specific active ingredient Carbidopa monohydrate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Co-careldopa 12.5mg/50mg tablets (Medihealth (Northern) Ltd) 90 tablet Has AMP True Co-careldopa 12.5mg/50mg tablets (Medihealth (Northern) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start